EMA: Improving safety of first-in-human clinical trials

EMA starts EU-wide reflection on necessary changes to best practices. The European Medicines Agency (EMA) has started a review of the guidelines that describe first-in-human clinical trials and the data needed to enable their appropriate design and allow initiation. This is being done in cooperation with the European Commission and the Member States of the European Union (EU).